+44 (0) 1698 534002
Contact

News

Graham Simpson MSP visits BioAscent

05 July 2019

BioAscent welcomed Graham Simpson, MSP for Central Scotland, on site this week to showcase its biology, chemistry and st...

Read more

BIA Report – Life sciences: catalysing investment and growth (2)

05 July 2019

A recent report from the UK Bioindustry Association (BIA), sets out how the UK life sciences sector is driving investmen...

Read more

BioAscent records successful first year as fully integrated discovery services CRO

20 June 2019

BioAscent Discovery Limited has announced a three-fold increase in revenues during 2018, with projections on-track for a...

Read more

BioAscent chosen as partner for European Lead Factory’s ESCulab project

13 May 2019

The European Lead Factory, Europe’s largest collaborative drug discovery platform, has selected BioAscent as a partner i...

Read more

BioAscent announced as CRO partner for Medicines Discovery Catapult Virtual R&D group

03 May 2019

BioAscent has been selected as one of the world-class CRO partners tasked with delivering support to the UK Medicines Di...

Read more

BioAscent collaborates with Heriot-Watt University on heart stent inflammation drug discovery program

23 April 2019

Scientists at Heriot-Watt University and the European Screening Centre (now part of BioAscent) have collaborated to find...

Read more

Maximising efficient compound management

02 April 2019

BioAscent COO and Co-founder, Sylviane Boucharens, and Chief Commercial Officer, Mike Piper, were recently interviewed f...

Read more

BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness

06 November 2018

BioAscent’s COO, Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness...

Read more

BioAscent appoints new Directors of Chemistry and Biosciences to lead integrated drug discovery services

29 August 2018

NEWHOUSE, UK (29 August 2018): BioAscent Discovery Limited (www.bioascent.com) has announced the appointments of Angus M...

Read more

BioAscent secures investment to expand its integrated drug discovery services

26 June 2018

BioAscent has secured £1.6m in funding from Maven Capital Partners (“Maven”).The investment will facilitate BioAscent’s...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact